We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about clear cell ovarian cancer, a rare but potentially aggressive subtype. Understand its symptoms, diagnosis, treatment, and outlook for better health awareness.

Ovarian cancer is a significant health concern for women, and understanding its various subtypes is crucial for early detection and effective treatment. Among these, clear cell ovarian cancer stands out as a less common but potentially more aggressive form. This guide aims to provide a detailed overview of clear cell ovarian cancer, tailored for an Indian audience, covering its characteristics, symptoms, diagnosis, treatment, and outlook.
Clear cell ovarian cancer is a specific subtype of epithelial ovarian cancer, which is the most common type of ovarian cancer. Epithelial ovarian cancer originates from the cells that form the outer lining of the ovaries. Clear cell ovarian cancer, also known as clear cell carcinoma, accounts for approximately 6% of all ovarian cancer cases. While it shares similarities with other ovarian cancers, its unique cellular structure and behavior warrant a closer look.
To better understand clear cell ovarian cancer, it's helpful to know the three main types of ovarian cancer:
Clear cell ovarian cancer falls under the epithelial category. It is often classified as a “high grade” tumor. This classification means that under a microscope, the cancer cells appear more abnormal and have a greater tendency to grow and spread rapidly compared to “low grade” tumors.
The term “aggressive” in the context of cancer refers to how quickly it grows and spreads (metastasizes). Clear cell ovarian cancer is generally considered more aggressive because it tends to grow and spread more rapidly than some other types of ovarian cancer. While many ovarian cancers are diagnosed at later stages, a significant portion of clear cell ovarian cancers are often diagnosed at earlier stages (Stage 1 or Stage 2). This is because they can sometimes present as a large mass on one ovary, making them more noticeable.
When clear cell ovarian cancer spreads, it can do so through several pathways:
Common sites for metastasis (spread) include the lymph nodes, uterus, abdominal lining, liver, lungs, bones, and sometimes the brain.
The symptoms of clear cell ovarian cancer can be similar to those of other ovarian cancers, and they often develop gradually. Early-stage symptoms may be subtle or absent. As the cancer progresses, symptoms can become more pronounced. It's important to note that these symptoms can also be caused by less serious conditions, but persistent or worsening symptoms should always be evaluated by a doctor.
Common symptoms include:
It is noteworthy that clear cell ovarian cancer is often diagnosed at a younger age compared to other types of ovarian cancer. The median age at diagnosis for clear cell ovarian cancer is around 55 years, whereas for the most common type, serous ovarian cancer, it's around 64 years.
Diagnosing clear cell ovarian cancer involves a combination of methods:
The treatment approach for clear cell ovarian cancer is similar to other ovarian cancers but may be adjusted based on the cancer's stage, grade, and the patient's overall health. The primary treatment is usually surgery, followed by chemotherapy.
The goal of surgery is to remove as much of the cancer as possible. This typically involves:
The extent of surgery depends on the stage of the cancer.
Chemotherapy is often used after surgery to kill any remaining cancer cells. Platinum-based chemotherapy drugs are commonly used. However, studies suggest that clear cell ovarian cancer may be less sensitive to platinum-based chemotherapy compared to other types of ovarian cancer. The effectiveness can range from 20-50%.
Research is ongoing for new treatment options:
The outlook for clear cell ovarian cancer can vary significantly based on the stage at diagnosis. Early-stage diagnosis (Stage 1 or 2) generally offers a more positive prognosis, with a higher survival rate. For instance, in one study, the 3-year survival rate for Stage 1 disease was over 90%.
However, the outlook for advanced-stage clear cell ovarian cancer (Stage 3 or 4) is less favorable, partly due to its potential resistance to standard chemotherapy. The 3-year survival rates for Stage 3 and Stage 4 disease were reported as 53.3% and 29.6%, respectively, in a study.
Recurrence is also a possibility. Some studies indicate that a significant percentage of patients may experience a recurrence after treatment, and recurrent clear cell ovarian cancer can be challenging to treat.
Currently, there are no definitive ways to prevent clear cell ovarian cancer. However, understanding risk factors can help in early detection:
Maintaining a healthy lifestyle, including a balanced diet and regular exercise, is always beneficial for overall health and may play a role in cancer prevention, though direct links to clear cell ovarian cancer prevention are not firmly established.
It is crucial to consult a doctor if you experience any persistent or concerning symptoms, especially those related to your reproductive health or abdomen. Don't ignore symptoms like unexplained bloating, pelvic pain, or changes in bowel or bladder habits. Early detection significantly improves the chances of successful treatment for any type of cancer, including clear cell ovarian cancer.
Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026